Year: 2020

SÃO PAULO, Brazil, Nov. 13, 2020 (GLOBE NEWSWIRE) — Vasta Platform Limited (NASDAQ: VSTA) – “Vasta” or the “Company,” announces today its financial and operating results for the third quarter of 2020 (3Q20) ended September 30, 2020. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).HIGHLIGHTSWith the completion of the 2020 sales cycle (4Q19 to 3Q20), Vasta reported a subscription revenue of R$692 million, which represents 18% increase in comparison to the subscription revenue for the 2019 sales cycle (R$584 million), or 21% higher than the ACV 2019 (R$572 million), and reinforces the resilience of our business by showing a solid result even during a period of strong socioeconomic instability caused by the pandemic.The subscription revenue for...

CHICAGO, Nov. 13, 2020 (GLOBE NEWSWIRE) — Professional Diversity Network, Inc. (NASDAQ:IPDN), (“IPDN” or the “Company”), a global developer and operator of online and in-person networks that provide access to networking, training, educational and employment opportunities for diverse individuals, today announced its financial results for the three and nine months ended September 30, 2020.Third Quarter Financial Highlights:Total Company revenues increased by $354,000 or 37.2%, from $952,000 during the three months ended June 30, 2020, to $1,306,000 for the three months ended September 30, 2020.PDN Network revenues increased by $389,000 or 65.1% compared to the revenues for the second quarter of 2020. The significant increase in revenues was attributable to higher customer acquisitions and continued growth in our recruitment business...

Valoe Corporation                           Stock Exchange Release 13 November 2020 at 15.15 Finnish timeISSUE OF CONVERTIBLE NOTES AND WARRANTS AND CONVERSION OF CONVERTIBLE NOTES PURSUANT TO FINANCING ARRANGEMENT BETWEEN VALOE CORPORATION AND WINANCEValoe Corporation (“Valoe” or the “Company”) has, pursuant to the terms and conditions of the financing arrangement between Valoe Corporation and Winance announced on 22 April 2020, withdrawn a total of EUR 200,000 of the third convertible notes tranche and issued to Winance in total 200 convertible notes and in total 800,000 warrants related thereto.Further, the Board of Directors of Valoe has, pursuant to the terms and conditions of the financing arrangement between Valoe Corporation and Winance announced on 22 April 2020, resolved to approve the request of Winance to convert...

Valoe Oyj                                      Pörssitiedote 13.11.2020 klo 15.15VALOE OYJ:N JA WINANCEN VÄLISEN RAHOITUSJÄRJESTELYN MUKAISTEN VAIHTOVELKAKIRJALAINOJEN JA WARRANTTIEN LIIKKEESEENLASKU JA VAIHTOVELKAKIRJALAINOJEN VAIHTAMINEN OSAKKEIKSIValoe Oyj (”Valoe” tai “Yhtiö”) on 22.4.2020 julkistetun Yhtiön ja Winance Investmentin (”Winance”) välisen rahoitusjärjestelyn (”Rahoitusjärjestely”) ehtojen mukaisesti nostanut 200.000 euroa Rahoitusjärjestelyn mukaisesta kolmannesta Lainaerästä sekä antanut Winancelle siihen liittyen yhteensä 200 vaihtovelkakirjaa ja 800.000 warranttia.Lisäksi Valoen hallitus on 22.4.2020 julkistetun Yhtiön ja Winancen välisen rahoitusjärjestelyn ehtojen mukaisesti päättänyt hyväksyä Winacen pyynnön vaihtaa 50.000 euron vaihtovelkakirjalainaosuus Yhtiön osakkeiksi merkintähinnalla 0,04 euroa...

Additional data from SIGNAL Huntington’s disease (HD) trial support continued development in HD and in Alzheimer’s disease (AD)Phase 1/2 Study to Evaluate Pepinemab in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for H1 2021Ended the quarter with cash and cash equivalents of $17.1 millionROCHESTER, N.Y., Nov. 13, 2020 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company developing innovative therapies for the treatment of neurodegenerative diseases and cancer, and supporting multiple collaborations with large biotech and major pharma partners through a proprietary discovery platform that enables selection of high value antibodies to difficult multipass membrane receptors, today announced financial results for the third quarter ended...

– PEDFIC 1 meets both U.S. and EU primary and secondary endpoints with highly statistically significant reductions in serum bile acids and pruritus –– Interim results from long-term extension study show sustained improvements in serum bile acids, pruritus –– Improvements in growth measures and liver parameters observed with long-term administration suggests disease modifying potential of odevixibat –– Treatment effect consistent across wide range of PFIC patient types 1, 2 and 3 –– Next-generation, novel bile acid modulators for adult liver diseases unveiled, including compound A3907 –BOSTON, Nov. 13, 2020 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced new data in...

National, November 12, 2020: BankBazaar.com, India’s leading free credit score provider and online financial product marketplace, announced comprehensive hiring plans to support business expansion. The company, which recently announced that its revenues are back to 70% of the peak pre-Covid revenue, has plans to scale up its digital KYC offerings to facilitate contactless access to credit. Majority of the 500+ hires would be for the Technology and Customer Service domains as BankBazaar looks to accelerate innovation and enable faster integration of Digital KYC and analytics solutions – the key growth drivers for the company. Hiring will take place across all BankBazaar locations in Chennai, Bangalore, and Mumbai. BankBazaar had a great run in the first five months of H2-FY20 and was trending to hit EBITDA positivity when Covid-19 hit in...